IndiaBanks.org · independent research

Business, & agriculture finance

Canara Pharma

Pharmaceutical-sector working-capital, non-fund and term finance above ₹10 lakh up to ₹50 crore, with trader working-capital cap of ₹10 crore and term repayment up to 10 years.

Facility amountAbove ₹10 lakh and up to ₹50 crore; traders' working-capital maximum is ₹10 crore.RateRate linked to security/collateral value and internal/external risk rating under RLLR-linked MSME lending; no fixed percentage is printed.Customer typeMSMEs manufacturing pharmaceuticals, APIs/API intermediates or trading pharmaceuticals as wholesale, retail or C&F agents.
Official product page ↗Compare category

Quick eligibility check

Canara Pharma

0 of 5 answered

Answer what you know. This guide compares your answers with the criteria published for this product; it is not an approval decision. Your answers stay on this device.

1Do you meet this requirement: MSMEs manufacturing pharmaceuticals, APIs/API intermediates or trading pharmaceuticals as wholesale, retail or C&F agents?

Published source: Customer type

2Document checkDo you have this required document or proof: NF998 MSME application and KYC?

Published source: Documents

3Document checkDo you have this required document or proof: Unit/promoter address proof?

Published source: Documents

4Document checkDo you have this required document or proof: Licences/permissions?

Published source: Documents

5Document checkDo you have this required document or proof: Last three years financial papers with ITR/projections?

Published source: Documents
0 of 5 answeredAnswer the remaining questions to see your checklist result.
✓ Manually checked 4 Sept 2026 · active
Offered byCanara Bank

India; presently implemented in Ahmedabad, Bhopal, Chandigarh and Karnal circles

Key facts

What the official sources publish

Every value belongs to this exact product. Expand any fact to inspect its official evidence in place.

Customer typeMSMEs manufacturing pharmaceuticals, APIs/API intermediates or trading pharmaceuticals as wholesale, retail or C&F agents.View source
Complete target-group section reviewed.
Source
Canara Pharma
Page / section
Target group
Accessed
4 Sept 2026
Confidence
high
Open official source ↗
Turnover / vintageNo numeric turnover or vintage floor is published; valid Udyam, Moderate Risk/BB or better, no recent SMA1/SMA2 or NPA and applicable CMR rules apply.View source
Complete eligibility section reviewed; no numeric turnover floor is published.
Source
Canara Pharma
Page / section
Eligibility
Accessed
4 Sept 2026
Confidence
high
Open official source ↗
Facility amountAbove ₹10 lakh and up to ₹50 crore; traders' working-capital maximum is ₹10 crore.View source
Complete quantum section reviewed.
Source
Canara Pharma
Page / section
Quantum of loan
Accessed
4 Sept 2026
Confidence
high
Open official source ↗
RateRate linked to security/collateral value and internal/external risk rating under RLLR-linked MSME lending; no fixed percentage is printed.View source
Complete pricing reference reviewed.
Source
Canara Pharma
Page / section
Rate of interest
Accessed
4 Sept 2026
Confidence
high
Open official source ↗
RepaymentWorking capital one year; term loan up to 10 years including maximum two-year moratorium.View source
Complete repayment section reviewed.
Source
Canara Pharma
Page / section
Repayment period
Accessed
4 Sept 2026
Confidence
high
Open official source ↗
Security / marginPrimary financed assets are charged; collateral may be land/building or approved financial securities. Term-loan margin 20%, fund-based working capital 25%, export pre-shipment 10%, post-shipment nil and NFB 15%; CGTMSE is not eligible.View source
Complete security/margin/ sections reviewed.
Source
Canara Pharma
Page / section
Security, margin and coverage
Accessed
4 Sept 2026
Confidence
high
Open official source ↗
FeesUpfront, processing, NFB commission, appraisal and commitment charges may receive 50% concession for Low risk, 25% for Normal risk and no concession for Moderate risk.View source
Complete rating/concession table reviewed.
Source
Canara Pharma
Page / section
Processing charges
Accessed
4 Sept 2026
Confidence
high
Open official source ↗
DocumentsNF998 application, KYC/address proof, licences, three years financial papers with ITR/projections, guarantor asset details and stock statement.View source
Published document list reviewed.
Source
Canara Pharma
Page / section
Documents
Accessed
4 Sept 2026
Confidence
high
Open official source ↗
Geographic limitsPAN India scheme, presently implemented in Ahmedabad, Bhopal, Chandigarh and Karnal circles.View source
Complete circle listing reviewed.
Source
Canara Pharma
Page / section
Geography
Accessed
4 Sept 2026
Confidence
high
Open official source ↗

Benefits and features

  • Facility above ₹10 lakh up to ₹50 crore; trader working capital capped at ₹10 crore
  • Term-loan margin 20%, working capital 25%, export pre-shipment 10%, post-shipment nil and NFB 15%
  • Working-capital one year; term loan up to 10 years including two-year moratorium
  • Up to 50% charge concession for low-risk borrowers; not eligible

Eligibility

  • Pharmaceutical/ manufacturing or trading units with Udyam registration, risk rating up to Moderate Risk/BB, no recent SMA1/SMA2 or and applicable Rank rules.

Passing a listed condition does not mean the bank will approve an application.

Documents the bank lists

  • NF998 application and
  • Unit/promoter address proof
  • Licences/permissions
  • Last three years financial papers with /projections
  • Guarantor asset details
  • Stock statement

Related official documents

Canara MSME Pharmaofficial-product-page · current · accessed 4 Sept 2026
↗

Plan before applying

Try the numbers

Private, instant and based on the values you enter.

Try your numbers

Loan repayment estimate

See what the loan could cost each month. Move any slider to try a different amount, rate or repayment time.

One monthly payment₹21,696twenty-one thousand six hundred ninety-six rupees
Interest paid over the full loan₹27,06,939twenty-seven lakh six thousand nine hundred thirty-nine rupees
Everything you repay₹52,06,939fifty-two lakh six thousand nine hundred thirty-nine rupees

This is only an estimate, not a bank or insurer offer. The final amount can change because of taxes, fees, rate changes and provider rules.

Use the published table

Find the exact published value

Choose a table, then pick its row and column. This shows the exact entry published by the bank or insurer without making you scan every cell.

INN · CustomerHospitality

This value is copied from Canara hospitality and pharmaceutical terms. Check the table notes before relying on it.

Source: Canara INN and Pharma pages · Complete product tables Open official source ↗

Published tables

Complete rates, limits and schedules

Tables preserve every reviewed row and column from the cited official source.

Table 1 · 2 rows · 7 columnsCanara hospitality and pharmaceutical MSME termsView tableHide table

Scroll sideways to view every column

Canara hospitality and pharmaceutical MSME terms
ProductCustomerFacility amountRateSecurity / marginRepaymentFees
INNHospitality Above ₹10 lakh–₹25 crore; WC up to ₹5 croreRisk/security-linked TL 20%, SOD nil, NFB 15%; 100% term securityWC 1 year; TL 10 years incl. 2-year moratoriumLow/normal/moderate concession 50%/25%/0%
PharmaPharmaceutical/ manufacturing and trading Above ₹10 lakh–₹50 crore; trader WC cap ₹10 croreRisk/security-linked TL 20%, WC 25%, export 10%/nil, NFB 15%; not eligibleWC 1 year; TL 10 years incl. 2-year moratoriumLow/normal/moderate concession 50%/25%/0%
Canara INN and Pharma pages · Complete product tables · accessed 4 Sept 2026Open official source ↗

More from Canara Bank

Related products

Canara Bank Guarantee

Non-fund-based guarantee facility for financial, performance and deferred-payment obligations, with margin, security, commission and period set under Canara Bank norms.

View product

Canara BE-MSME (Manufacturing) Bill Discounting

Concessional bill-of-exchange discounting/purchase for genuine manufacturing trade transactions, including pre-accepted bills and bills drawn under eligible inland letters of credit.

View product

Canara CGTMSE Credit Guarantee

guarantee support for Canara credit up to ₹2 crore, enabling finance with no or partial collateral and third-party guarantee.

View product

Canara Credit Guarantee Scheme for Exporters (CGSE)

Government-backed guarantee support for eligible export working-capital borrowers, covering up to 20% of limits up to ₹50 crore for four years including a one-year moratorium.

View product